Zobrazeno 1 - 10
of 44
pro vyhledávání: '"G. J. Kahaly"'
Autor:
P. Perros, L. Hegedüs, L. Bartalena, C. Marcocci, G. J. Kahaly, L. Baldeschi, M. Salvi, J. H. Lazarus, A. Eckstein, S. Pitz, K. Boboridis, P. Anagnostis, G. Ayvaz, A. Boschi, T. H. Brix, N. Currò, O. Konuk, M. Marinò, A. L. Mitchell, B. Stankovic, F. B. Törüner, G. von Arx, M. Zarković, W. M. Wiersinga
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-6 (2017)
Abstract Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status. Current evidence suggests that the incidence of GO in Europe may
Externí odkaz:
https://doaj.org/article/411a63ef25e042908de19019e062161d
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
The clinical utility of the functional TSH receptor autoantibodies was prospectively evaluated in patients with thyroid-associated orbitopathy (TAO). Ophthalmic, endocrine, and serological investigations were performed in 101 consecutive patients wit
Externí odkaz:
https://doaj.org/article/9fd67a9c5d5f4826922d4c16df60e991
Purpose Orbital fibroblasts (OF) are considered the central target cells in the pathogenesis of thyroid-associated orbitopathy (TAO), which comprises orbital inflammation, orbital tissue edema, adipogenesis, fibrosis, oxidative stress and autophagy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d4bbe08afc63e95733546dfc227e615
Autor:
M. Sarić Matutinović, G. J. Kahaly, M. Žarković, J. Ćirić, S. Ignjatović, B. Nedeljković Beleslin
Publikováno v:
Journal of Endocrinological Investigation
Purpose: Graves’ orbitopathy (GO) is a specific inflammatory disorder of the orbit characterized by a highly heterogeneous clinical phenotype. The role of thyrotropin receptor antibodies (TSH-R-Ab) has been widely researched, however there is still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0acec4ccdec66fbf48377c9091b6cea
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4654
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4654
Autor:
M, Sarić Matutinović, T, Diana, B, Nedeljković Beleslin, J, Ćirić, M, Žarković, G J, Kahaly, S, Ignjatović
Publikováno v:
Journal of endocrinological investigation. 45(1)
Thyrotropin receptor autoantibodies (TSH-R-Ab) are heterogeneous in their biological function and play a significant role in the pathophysiology of both Graves' disease and Graves' orbitopathy (GO). The clinical significance and utility of determinin
Autor:
L Bartalena, G J Kahaly, L Baldeschi, C M Dayan, A Eckstein, C Marcocci, M Marinò, B Vaidya, W M Wiersinga, Goksun Ayvaz, Onur Konuk, Jasmina Ciric, Bijliana Beleslin, Antonella Boschi, Maria Cristina Burlacu, Dan Morris, Rosario Le Moli, Antonio Marino, Justin McKee, Nicola Zammit, Dagmar Führer, Ioana Pereni, Michael Schittkowski, Dirk Raddatz, Vickie Lee, Karim Meeran, Juliette Abeillon, Thia Soui Thcong, Katharina Ponto, Ilaria Muller, Nicola Currò, Christoph Hintschich, Roland Gärtner, Simon Pearce, Lucy Clarke, Thomas Brix, Dorte Bechtold, Gottfried Rudovfsky, Nicole Fichter, Laurence Du Pasquier, Julia Meney, Francesca Menconi, Giulia Lanzolla, Gangadhara Sundar, Samantha Peiling Yung, Kostas Boboridis, Panagiotis Anagnostis, Marta Pérez Lopez, Carlos Javier Sanchez, Maria Laura Tanda, Simone Donati, Andrea Papp, Shuren Li, Anna Jablonska, Piotr Miskiewicz, Jelena Juri Mandic, Maja Baretic
Publikováno v:
European journal of endocrinology, Vol. 185, no. 4, p. G43-G67 (2021)
European Journal of Endocrinology, 185(4), G43-G67. BioScientifica Ltd.
European Journal of Endocrinology, 185(4), G43-G67. BioScientifica Ltd.
Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71629229c4ad08577973ef207b8d40a5
https://doi.org/10.1530/eje-21-0479
https://doi.org/10.1530/eje-21-0479
Publikováno v:
Der Internist. 58:308-328
Polyglandular autoimmune syndromes encompass several endocrine and nonendocrine autoimmune disorders with variable onset and phenotype. Rheumatoid and gastroenterological symptoms in patients with autoimmune polyglandular syndromes are suggestive of
Publikováno v:
Diabetic Medicine. 32:1177-1185
Aims Body cell mass is directly proportional to the bioimpedance phase-angle which is an indicator of the amount of electrical charge that cell membranes can hold and is an index of cellular health and function. To evaluate whether the bioimpedance p
Autor:
A. Marković, S. Barkia, M.-C. Haager, G. J. Kahaly, A. Janson, J. Bux, C. Weinstock, N. Matheis
Publikováno v:
Tissue Antigens. 77:317-324
Autoimmune polyglandular syndrome (APS) type 2 is defined by the manifestation of at least two autoimmune endocrine diseases. Only few data exist on genetic associations of APS type 2. In this controlled study, 98 patients with APS type 2, 96 patient
Publikováno v:
Hormone and Metabolic Research. 43:200-204
Data regarding familial prevalence and recurrence risk ratio of autoimmune thyroid diseases (AITD) in Germany are lacking. The data from 179 German families of AITD patients encompassing 1 229 relatives were collected using standardized clinical and